EXC vs MRSN · P/E 17, rev $24.26B vs rev $40.5M
Exelon Corporation (EXC) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the EXC and MRSN stock pages for the full models.
Not investment advice.